Loading...

GLYCOSYLATION (CDG) DISORDER GENE PROFILE

image not found

NABL Cap Accredited 
The Glycosylation (CDG) Disorder Gene Profile analyzes a wide spectrum of genes involved in congenital disorders of glycosylation, a group of rare metabolic conditions affecting multiple organ systems. This test helps detect mutations that impair proper protein glycosylation and cellular functioning. Metropolis Healthcare uses advanced next-generation sequencing to ensure precise identification of clinically relevant variants. The results support early diagnosis, subtype differentiation, and personalized clinical management

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:G0201

Frequently Asked Questions (FAQ's):

What does the Glycosylation (CDG) Disorder Gene Profile include at Metropolis Healthcare?
It evaluates multiple genes known to cause congenital disorders of glycosylation using high-accuracy next-generation sequencing.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from a blood sample and sequences targeted genes using advanced NGS technology.

Who should consider taking this test at Metropolis Healthcare?
Individuals with developmental delays, hypotonia, unexplained liver issues, abnormal labs, or suspected CDG may benefit from this profile.

What sample is required for this test at Metropolis Healthcare?
A standard blood sample is sufficient for accurate genetic sequencing and analysis.

How long does Metropolis Healthcare take to deliver the results?
Turnaround time varies based on sequencing and interpretation steps, with reports shared promptly once analysis is complete.

Why choose Metropolis Healthcare for this genetic profile?
Metropolis Healthcare ensures comprehensive gene coverage, strict quality checks, and clinically meaningful interpretation.

Does Metropolis Healthcare offer post-test guidance?
Yes, expert genetic insights accompany the results to help clinicians manage CDG-related conditions effectively.

Is this test suitable for infants and children at Metropolis Healthcare?
Yes, the test is appropriate for newborns, children, and adults when CDG is clinically suspected

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab